← Open Payments lookup

GREGORY WASHINGTON: Open Payments

NPI 1568679314 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$805 in 46 payments from 9 companies in 2025. Trend: 2023 $194 · 2024 $1,301 · 2025 $805

Food & beverage: $694Education: $111
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc12$167
Neurocrine BioSciences, Inc.11$152
Otsuka America Pharmaceutical, Inc.11$152
Teva Pharmaceuticals USA, Inc.1$111
E.R. Squibb & Sons, L.L.C.3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Alkermes, Inc.2$42
Noven Therapeutics, LLC2$35
Vanda Pharmaceuticals Inc.1$28

Products named: INVEGA SUSTENNA, INGREZZA, REXULTI, COBENFY, CAPLYTA, ARISTADA, Secuado, ABILIFY MAINTENA.

Industry payments across MI — which companies pay providers there.